4//SEC Filing
Dowden Nathan J 4
Accession 0001689375-24-000056
CIK 0001689375other
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 4:32 PM ET
Size
4.8 KB
Accession
0001689375-24-000056
Insider Transaction Report
Form 4
Dowden Nathan J
President & COO
Transactions
- Sale
Common Stock
2024-09-26$16.00/sh−847$13,552→ 125,149 total
Footnotes (1)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 8, 2024.
Documents
Issuer
Entrada Therapeutics, Inc.
CIK 0001689375
Entity typeother
Related Parties
1- filerCIK 0001873392
Filing Metadata
- Form type
- 4
- Filed
- Sep 29, 8:00 PM ET
- Accepted
- Sep 30, 4:32 PM ET
- Size
- 4.8 KB